The trademark application UVADEX was filed by Mallinckrodt Pharmaceuticals Ireland Limited, a corporation established under the laws of Ireland (the "Applicant"). The application was published for oppositions on October 11, 2022, and it was registered by office on January 18, 2023 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on January 11, 2024. Creation of rights in rem of the trademark registration was recorded on April 15, 2024.